Researchers from Truveta have found that adoption of adalimumab biosimilars increased substantially following formulary changes in the United States, though more than one in seven patients who ...
Adalimumab is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic psoriasis, hidradenitis suppurativa, and ...
I hit the buy button on AbbVie (NYSE:ABBV | ABBV Price Prediction) again last week, and I will hit it again the next time June’s macro noise hands me a discount. While short-term traders chase ...
This drug has boxed warnings. These are the most serious warnings from the Food and Drug Administration (FDA). A boxed warning alerts doctors and patients about drug effects that may be dangerous.
AbbVie's post-Humira growth story has been a triumph, but the single drug driving that narrative is showing the first hint of ...
AbbVie expects erosion of roughly 45% in sales of Humira when it faces biosimilar challengers in 2023. As for guidance on a revenue figure for the treatment that year, AbbVie says wait until the third ...
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services Evernorth Health, a wholly owned subsidiary of Cigna ...
The drugmaker has successfully replaced its former blockbuster, but buying into that victory today means paying a steep ...
CVS Health is the first major player to end some of its Humira coverage in order to make way for biosimilars. (CVS) This year, CVS Health plans to employ the classic "out with the old, in with the new ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. In a unique challenge to drug makers, the Dutch Pharmaceutical ...
Collectively, the top 10 blockbuster drugs of 2023 generated over $131 billion in sales last year. Looking closer at these figures provides insight into the shifting landscape of the pharmaceutical ...